Trial Metric Retatrutide 12mg (TRIUMPH-4) Semaglutide 2.4mg (STEP 1) Mean Weight Loss 28.7% at 68 weeks 14.9% at 68 weeks Mechanism Triple agonist (GLP-1/GIP/GCGR) Single agonist (GLP-1) FDA Status Phase 3 (investigational) Approved (Wegovy) Dosing Weekly subcutaneous Weekly subcutaneous Common Adverse Events GI (nausea, vomiting, diarrhea), dysesthesia GI (nausea, vomiting, diarrhea) Important caveat: These results come from different trial populations and study designs
Notably, the trimethoxy analogs showed improved COX-2 Selectivity Index (SI) values, surpassing that of celecoxib
High-resolution structural biology, including cryo-electron microscopy and computational modeling, has enabled detailed mapping of peptidereceptor interactions, informing rational design and selectivity optimization
For most patients in our clinics, the honest answer is neither, yet
Once on, they did leave a slight stain on the lips, but it was easy to remove with makeup remover (I used the Clinique Take the Day Off)
[DOI] [PMC free article] [PubMed] [Google Scholar] 2.Klein S., Gastaldelli A., Yki-Jrvinen H., Scherer P.E